Skip to primary navigation
Skip to main content
Skip to footer
Home
LinkedIn
Twitter
About Us
Overview
Executive Committee
Board Of Directors
Newsroom
Scientific Publications
Press Releases
Events
Partnering
Investors
Overview
Corporate Governance
Regulated Information
Shareholders Information
Shareholders Meeting
Contact Us
ASH: Data from CYAD-02 CYCLE 1 Phase 1 study and CYAD-211 IMMUNICY-1 Phase 1 study
December 13, 2021
